Medical Equipment & Devices
FNArena Windows (Sectors)
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
Latest Stories
Lack of competition, alongside improved component supply, sees ResMed deliver a strong second quarter
Jan 31 2023
Following a change to a direct distribution model, Nanosonics has delivered a better than expected first half, but brokers remain cautious
Jan 24 2023
| ASX CODE | COMPANY NAME | LAST PRICE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET |
|---|---|---|---|---|---|---|
| CBL | CONTROL BIONICS LIMITED | $0.18 | $0.46 | $0.12 |
$0.85 |
|
| COH | COCHLEAR LIMITED | $212.50 | $236.43 | $184.62 | 47.3 |
$215.783 |
| EBR | EBR SYSTEMS INC | $0.63 | $0.83 | $0.33 |
$0.987 |
|
| FPH | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED | $23.61 | $28.89 | $16.11 | 64.6 |
$21.75 |
| IDX | INTEGRAL DIAGNOSTICS LIMITED | $3.17 | $4.28 | $2.38 | 27.3 |
$2.804 |
| IME | IMEXHS LIMITED | $0.40 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IPD | IMPEDIMED LIMITED | $0.06 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MX1 | MICRO-X LIMITED | $0.14 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NAN | NANOSONICS LIMITED | $4.81 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PME | PRO MEDICUS LIMITED | $65.37 | $xx.xx | $xx.xx | xx.x | xx.xx |
| RMD | RESMED INC | $32.23 | $xx.xx | $xx.xx | xx.x | xx.xx |
| SOM | SOMNOMED LIMITED | $1.23 | $xx.xx | $xx.xx | xx.x | xx.xx |
| TRJ | SOMNOMED LIMITED | $1.86 | $xx.xx | $xx.xx | xx.x | xx.xx |
| VHT | VOLPARA HEALTH TECHNOLOGIES LIMITED | $0.81 | $xx.xx | $xx.xx | xx.x | xx.xx |
Previous Stories
Nanosonics Recovers On Less Negative Sentiment
Nov 29 2022
A turn in sentiment has allowed Nanosonics shares to recover, with (some) broker views turning less negative
Treasure Chest: Fisher & Paykel Healthcare
Nov 16 2022
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Fisher & Paykel Healthcare
Dr Boreham’s Crucible: Imricor Medical Systems
Oct 17 2022
Imricor is a player in a global catheter ablation market worth $US5.5 billion and growing at a compound rate of just over 8% a year
Market Share Gains Key to ResMed’s Outlook
Aug 15 2022
Following FY22 results, brokers set higher price targets for ResMed on average and expect market share gains
Dr Boreham’s Crucible: 4D Medical
Aug 08 2022
Dedicated lung imaging pioneer 4D medical sees itself as a software company, with lots of future potential, including from the US military
Treasure Chest: The Outlook For Cochlear
Jul 27 2022
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea regards Cochlear
Nanosonics’ Q4 Surprises, But Brokers See Risk
Jul 27 2022
Nanosonics’ June quarter update proved a positive surprise but most brokers cannot get past the many risks, also finding the shares look expensive
Benefits In View For Radiology AI Adopters
Jul 11 2022
After a huge step up in funding over the last three years, artificial intelligence in radiology may be approaching wider adoption across the sector
Brokers Divided Over ResMed’s SaaS Acquisition
Jun 16 2022
Following ResMed’s purchase of Medifox Dan, brokers remain upbeat though some question the benefits of SaaS acquisitions to date
Shortages Chip Away At ResMed’s Big Break
Mar 30 2022
ResMed has struggled to realise the benefit promised by a major competitor recall and heightened demand amid a global shortage of semiconductor chips necessary for device production
Latest News
| 1 |
ASX Winners And Losers Of Today – 02-02-23Feb 02 2023 - Daily Market Reports |
| 2 |
Australian Broker Call *Extra* Edition – Feb 02, 2023Feb 02 2023 - Daily Market Reports |
| 3 |
The Short Report – 02 Feb 2023Feb 02 2023 - Weekly Reports |
| 4 |
Westpac: Patience RequiredFeb 02 2023 - Technicals |
| 5 |
Headwinds Versus Tailwinds For Banks in 2023Feb 02 2023 - Australia |
